Shenk, Kevin D.,Parlati, Francesco,Bennett, Mark K.
申请号：
AU2011223795
公开号：
AU2011223795A1
申请日:
2011.03.01
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
